UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms of major depression ...
University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...
At the same time, with a growing number of clinics dispensing the psychedelic drug ketamine as a treatment for depression, a vital question arises. Is ketamine a breakthrough, or are so-called ...
Today, Mindbloom, the largest provider of psychedelic therapy, and Happier, the leading meditation and habit-building app, announce Continuous Transformation – a partnership to enable people to deepen ...
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...